Metabolomics Market Size, Share, Forecast Report, 2020-2027

The global Metabolomics market garnered revenue around USD 2.1 Billion in 2020 and projected to reach USD 4.5 Billion in 2027, with at a compound annual growth rate (CAGR) of 13.8% throughout the estimate period from 2020 to 2027. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, availability of government and private funding for metabolomics research,  and ongoing innovations in metabolomics instruments are driving the growth of the global metabolomics industry.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Metabolomics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Metabolomics market growth.

The global Metabolomics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The major market players include  The metabolomics market is dominated by a few globally established players such as Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US), Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US)

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

• By Product & Service
• Metabolomics Instruments
• Separartion Tools
• Gas Chromatography
•  High-performance Liquid Chromatography
•  Ultra-performance Liquid Chromatography
•  Capillary Electrophoresis
• Detection Tools
• Nuclear Magnetic Resonance (NMR) Spectroscopy
•  Mass Spectrometry (MS)
• Surface-Based Mass Analysis
• Bioinformatics Tools and Services
• Bioinformatics Services
• Bioinformatics Tools and Databases
• By Application
• Biomarker discovery
• Drug discovery
• Toxicology testing
• Nutrigenomics
• Functional Genomics
• Personalized medicine
• Other Applications
• By Indication
• Cancer
• Cardiovascular Disorders
•  Neurological Disorders
•  Metabolic Disorders
•  Inborn Errors of Metabolism
• Other Indications
• By End User
• Academic and Research Institutes
•  Pharmaceutical & Biotechnology Companies
•  Contract Research Organizations
•  Other End Users
• Company Type
• Tier 1 Pharmaceutical Companies
• Tier 2 Pharmaceutical Companies
• Tier 3 Pharmaceutical Companies

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• Italy
• France
• Rest of EU

Asia Pacific

• China
• India
• Japan
• Southeast Asia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of Central & South America

Middle East and Africa

• UAE
• Saudi Arabia
• Rest of MEA